Company Overview and News


Add NU
to your dashboard

Headline News

NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid

2017-11-06 marketwired
VANCOUVER, BC--(Marketwired - November 06, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation ("Ambarii") CBD products, Naturally Splendid USA ("Naturally Splendid"), expects final approval imminently from the Japanese government for distribution of CBD products in Japan. (5-0)

NeutriSci's Neuenergy(R) Launches in Quebec

2017-07-20 marketwired
VANCOUVER, BC--(Marketwired - July 20, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Sobeys gas bars and convenience stores in Quebec.

NeutriSci Announces Warrant Incentive Program

2017-07-07 marketwired
VANCOUVER, BC--(Marketwired - July 07, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that it will immediately implement an incentive program designed to encourage the early exercise of up to 1,722,333 warrants issued on September 30, 2015 (the "September 2015 Warrants"); and 13,013,000 warrants issued on November 25, 2015 (the "November 2015 Warrants"); and the exercise of up to 2,220,000 warrants issued on July 25, 2016 (the "July 2016 Warrants"); and the exercise of up to 1,667,000 warrants issued on September 30, 2016 (the "September 2016 Warrants"); and the exercise of up to 15,000,000 warrants issued on November 18, 2016 (the "November 2016 Warrants"); and the exercise of up to 3,333,000 warrants issued on May 2, 2017 (the "May 2017 Warrants" and together with the September 2015, November 2015, July 2016, September 2016, and November 2016 Warrants, the "Original Warrants").

NeutriSci Announces International Distribution Agreement and Initial Orders Into China, Hong Kong, Taiwan and Macau

2017-06-06 marketwired
VANCOUVER, BC--(Marketwired - June 06, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce its first major distribution agreement for neuenergy® into Greater China including Mainland China, Hong Kong, Taiwan and Macau.

NeutriSci Adds Esso Gas Bars and Convenience Stores to Its List of Canadian Retailers

2017-06-02 marketwired
VANCOUVER, BC--(Marketwired - June 01, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Esso gas bars and convenience stores representing 150 stores in Saskatchewan, Alberta and British Columbia.

NeutriSci's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea

2017-05-30 marketwired
VANCOUVER, BC--(Marketwired - May 30, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that its joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") and Naturally Splendid Enterprises Ltd. ("Naturally Splendid") have entered into a LOI for the sale and distribution of Ambarii's proprietary sublingual full spectrum hemp CBD tablets ("Ambarii CBD Tablets") in Japan and South Korea.

Lexaria's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea

2017-05-30 marketwired
VANCOUVER, BC--(Marketwired - May 30, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that its 50%-owned joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") has entered into a LOI with Naturally Splendid Enterprises Ltd. (TSX VENTURE: NSP) ("Naturally Splendid") for the production, sale and distribution of Ambarii's proprietary sublingual full spectrum hemp CBD tablets ("Ambarii CBD Tablets") in Japan and South Korea.

NeutriSci Completes Private Placement

2017-05-02 marketwired
VANCOUVER, BC--(Marketwired - May 02, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has completed a non-brokered private placement (the "Placement") in which it raised gross proceeds of $399,960.

Lexaria and Neutrisci Enter Cannabinoid Joint Venture

2017-04-10 marketwired
KELOWNA, BC--(Marketwired - April 10, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company") and Neutrisci International Inc ("Neutrisci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) have completed and signed the previously announced joint venture agreement (the "JV") to produce and commercialize a line of healthy, sugar-free, edible cannabinoid mouth-melt products which will utilize Lexaria's patented technology and Neutrisci's proprietary pterostilbene tablet form factor.

NeutriSci Forms Cannabinoid Joint Venture With Lexaria Bioscience

2017-04-10 marketwired
VANCOUVER, BC--(Marketwired - April 10, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) (OTCQB: LXRP) are pleased to announce finalization of the joint venture between the companies to produce and commercialize a line of healthy, sugar-free, edible cannabinoid sublingual tablets combining NeutriSci's proprietary pterostilbene tablet form factor and Lexaria's patented technology.

NeutriSci Announces Distribution Agreement & Initial Order of Neuenergy From Gateway Newstands

2017-03-16 marketwired
VANCOUVER, BC--(Marketwired - March 16, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Gateway Newstands across Canada and the United States.

NeutriSci Launches National Television Ad Campaign

2017-03-09 marketwired
VANCOUVER, BC--(Marketwired - March 09, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its national television campaign for neuenergy®.

NeutriSci Announces OTCQB Listing

2017-03-06 marketwired
VANCOUVER, BC--(Marketwired - March 06, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has commenced trading on the OTCQB Marketplace under the symbol NRXCF.

Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results From Initial Human Observational Trials

2017-01-19 marketwired
KELOWNA, BC--(Marketwired - January 19, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") and NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) are pleased to announce the successful development and initial trial of the industry's first zero-sugar cannabinoid / pterostilbene edible tablet utilizing both NeutriSci's and Lexaria's proprietary and patented technologies.

NeutriSci Announces Successful Development and Positive Results From Initial Observational Product Trials With Lexaria Bioscience

2017-01-19 marketwired
VANCOUVER, BC--(Marketwired - January 19, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) are pleased to announce the successful development and initial trial of the industry's first cannabinoid / pterostilbene edible tablet utilizing NeutriSci's and Lexaria's proprietary and patented technologies.